Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation

<b>Background</b>: Gegen Qinlian Decoction (GQD), is used for intestinal disorders like ulcerative colitis, irritable bowel syndrome, and colorectal cancer. But the precise mechanisms underlying its anti-inflammatory and anti-tumor effects are not fully elucidated. <b>Methods</b>: Use network pharma...

Повний опис

Бібліографічні деталі

Автори:	Yaoyao Xu, Qiaoyan Cai, Chunyu Zhao, Weixiang Zhang, Xinting Xu, Haowei Lin, Yuxing Lin, Daxin Chen, Shan Lin, Peizhi Jia, Meiling Wang, Ling Zhang, Wei Lin
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2024-12-01
Серія:	Pharmaceuticals
Предмети:	Gegen Qinlian Decoction colitis-associated colorectal cancer azoxymethane/dextran sodium sulfate inflammatory response network pharmacology TLR4 signaling pathway
Онлайн доступ:	https://www.mdpi.com/1424-8247/18/1/12
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!